We serve Chemical Name:1-methylsulfanyl-4-(trifluoromethoxy)benzene CAS:2546-45-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-methylsulfanyl-4-(trifluoromethoxy)benzene
CAS.NO:2546-45-4
Synonyms:1-Methylmercapto-4-trifluormethoxy-benzol;4-trifluoromethoxythioanisole
Molecular Formula:C8H7F3OS
Molecular Weight:208.20100
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:199.1ºC at 760mmHg
Density:1.3g/cm3
Index of Refraction:1.492
PSA:34.53000
Exact Mass:208.01700
LogP:3.30710
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-Methylmercapto-4-trifluormethoxy-benzol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-trifluoromethoxythioanisole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-trifluoromethoxythioanisole Use and application,4-trifluoromethoxythioanisole technical grade,usp/ep/jp grade.
Related News: Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. 1-methylsulfanyl-4-(trifluoromethoxy)benzene manufacturer According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 1-methylsulfanyl-4-(trifluoromethoxy)benzene supplier According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 1-methylsulfanyl-4-(trifluoromethoxy)benzene vendor The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1-methylsulfanyl-4-(trifluoromethoxy)benzene factory According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.
